Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis.
Eur J Gastroenterol Hepatol
; 36(8): 1022-1028, 2024 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-38973543
Full text:
1
Database:
MEDLINE
Main subject:
Quality of Life
/
Rifamycins
/
Rifaximin
/
Liver Cirrhosis
/
Midodrine
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2024
Type:
Article